mRNA: harnessing the benefits, addressing the challenges

VACCINE INSIGHTS

mRNA: harnessing the benefits, addressing the challenges

September 2022
mRNA: harnessing the benefits, addressing the challenges
Download PDF

Expert Insight

A blueprint for quality by digital design to support rapid RNA vaccine process development, manufacturing & supply

A blueprint for quality by digital design to support rapid RNA vaccine process development, manufacturing & supply

S Daniel, Z Kis, C Kontoravdi et al.
22 September 2022
Read

Innovator Insight

Discovery to delivery in 100 days: RNA therapeutics & their role in future pandemic preparedness

Discovery to delivery in 100 days: RNA therapeutics & their role in future pandemic preparedness

Tracy Humphries
10 November 2022
Read

Commentary

mRNA Vaccines: a growing and complex IP landscape

mRNA Vaccines: a growing and complex IP landscape

Robert Burrows, Ellen Lambrix
4 September 2022
Read

Interview

RNA vaccine production 4.0

RNA vaccine production 4.0

Zoltan Kis
4 September 2022
Read
RNA pioneer Ingmar Hoerr: from entrepreneur to philanthropist

RNA pioneer Ingmar Hoerr: from entrepreneur to philanthropist

Ingmar Hoerr
24 August 2022
Read

FastFacts

End-to-end solutions for mRNA development and manufacturing

End-to-end solutions for mRNA development and manufacturing

Susana Domingues-Vallon
21 November 2022
Read

Webinars

Process and analytical insights for GMP manufacturing of mRNA lipid nanoparticles

Process and analytical insights for GMP manufacturing of mRNA lipid nanoparticles

E Cameau, P Zhang, S Ip et al.
28 September 2022
Watch